Changes in Bone Mineral Density through 96 Weeks in Antiretroviral-Naïve HIV-1 Infected Patients Receiving Abacavir/Lamivudine and Raltegravir in the SHIELD Trial

Journals Menu

Follow SCIRP

ISSN Print: 2160-8814
ISSN Online: 2160-8822
www.scirp.org/journal/wja
E-mail: wja@scirp.org

Citations

"Changes in Bone Mineral Density through 96 Weeks in Antiretroviral-Naïve HIV-1 Infected Patients Receiving Abacavir/Lamivudine and Raltegravir in the SHIELD Trial"
written by Linda Battalora, Amy Thomas, Brian Wine, Belinda Ha, Benjamin Young,
published by World Journal of AIDS, Vol.4 No.1, 2014

has been cited by the following article(s):

[1]	HIV, Antiretroviral Therapy, Pregnancy, Lactation and Bone Health in Uganda
	2018

Follow SCIRP